In a porcine model of metabolic syndrome (MetS), the systemic administration of ADMSC-EVs restored kidney function and reduced tubulointerstitial fibrosis by IL-10-dependent immunoregulation (98). This evidence concerns the gene IL10 and metabolic syndrome.